{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:07:54Z","timestamp":1777867674763,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2320-B-400-012"],"award-info":[{"award-number":["106-2320-B-400-012"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["100-2314-B-400-002-MY3"],"award-info":[{"award-number":["100-2314-B-400-002-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["100-3112-B-400-015"],"award-info":[{"award-number":["100-3112-B-400-015"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.pnpbp.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T21:55:36Z","timestamp":1515534936000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment"],"prefix":"10.1016","volume":"83","author":[{"given":"Chia-Chen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiu-Ping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung-Hsia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiang-Wei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-8505","authenticated-orcid":false,"given":"Andrew C.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2018.01.008_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0165-5728(02)00050-4","article-title":"Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice","volume":"126","author":"Abbas","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey","volume":"2","author":"Anthony","year":"1994","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.01.008_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.52964\/AMJA.0285","article-title":"Problem based review: the patient taking methadone","volume":"12","author":"Arora","year":"2013","journal-title":"Acute Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2018.01.008_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.pnpbp.2018.01.008_bb0030","first-page":"353145","article-title":"The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease?","volume":"2012","author":"Borquez","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"51","key":"10.1016\/j.pnpbp.2018.01.008_bb0035","doi-asserted-by":"crossref","first-page":"51100","DOI":"10.1074\/jbc.M309561200","article-title":"Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1","volume":"278","author":"Chang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/glia.20451","article-title":"IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1\/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes","volume":"55","author":"Cho","year":"2007","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.pnpbp.2018.01.008_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1369-1600.2010.00265.x","article-title":"A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women","volume":"17","author":"Crystal","year":"2012","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.01.008_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086114","article-title":"Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis","volume":"9","author":"Dennis","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13825585.2013.819067","article-title":"Does substance abuse contribute to further risk of falls in dementia","volume":"21","author":"Eshkoor","year":"2014","journal-title":"Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn."},{"issue":"1","key":"10.1016\/j.pnpbp.2018.01.008_bb0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biopsych.2013.08.034","article-title":"Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways","volume":"76","author":"Gelernter","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2018.01.008_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2008.10.003","article-title":"Analysis of APBB2 gene polymorphisms in sporadic Alzheimer's disease","volume":"447","author":"Golanska","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.pnpbp.2018.01.008_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.exger.2013.01.013","article-title":"APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians","volume":"48","author":"Golanska","year":"2013","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.pnpbp.2018.01.008_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neurobiolaging.2013.08.032","article-title":"Interactions between GSK3beta and amyloid genes explain variance in amyloid burden","volume":"35","author":"Hohman","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12640-015-9541-0","article-title":"GSK3beta interactions with amyloid genes: an autopsy verification and extension","volume":"28","author":"Hohman","year":"2015","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2018.01.008_bb0090","first-page":"173","article-title":"Heroin addiction","volume":"81","author":"Hosztafi","year":"2011","journal-title":"Acta Pharm. Hung."},{"issue":"5","key":"10.1016\/j.pnpbp.2018.01.008_bb0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ALN.0000000000000867","article-title":"Methadone pharmacogenetics: CYP2B6 polymorphisms determine plasma concentrations, clearance, and metabolism","volume":"123","author":"Kharasch","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pnpbp.2018.01.008_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1747-597X-7-11","article-title":"Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan","volume":"7","author":"Lee","year":"2012","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/humu.20138","article-title":"Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease","volume":"25","author":"Li","year":"2005","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.pnpbp.2018.01.008_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response: impact of genetic polymorphism","volume":"12","author":"Li","year":"2008","journal-title":"Mol. Diagn. Ther."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2018.01.008_bb0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2010.12.007","article-title":"Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China","volume":"116","author":"Li","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2018.01.008_bb0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2015.05.055","article-title":"Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients","volume":"194","author":"Liu","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.pnpbp.2018.01.008_bb0125","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2353\/ajpath.2009.090059","article-title":"Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice","volume":"175","author":"Mastrangelo","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.pnpbp.2018.01.008_bb0130","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/bcp.12576","article-title":"Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity","volume":"79","author":"Mouly","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4064","key":"10.1016\/j.pnpbp.2018.01.008_bb0135","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.178.4064.984","article-title":"Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection","volume":"178","author":"Oldendorf","year":"1972","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.pnpbp.2018.01.008_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2018.01.008_bb0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.drugalcdep.2007.02.007","article-title":"The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program","volume":"89","author":"Raffa","year":"2007","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.pnpbp.2018.01.008_bb0150","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.drugpo.2013.05.003","article-title":"Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran","volume":"24","author":"Shariatirad","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.pnpbp.2018.01.008_bb0155","series-title":"R: A language and environment for statistical computing [Internet]","author":"Team","year":"2015"},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.pbb.2011.04.014","article-title":"Powerful behavioral interactions between methamphetamine and morphine","volume":"99","author":"Trujillo","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pnpbp.2018.01.008_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoactive Drugs"},{"issue":"2","key":"10.1016\/j.pnpbp.2018.01.008_bb0170","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","article-title":"Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice","volume":"170","author":"Yamamoto","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.pnpbp.2018.01.008_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005910","article-title":"Genome-wide Pharmacogenomic study on methadone maintenance treatment identifies SNP rs17180299 and multiple haplotypes on CYP2B6, SPON1, and GSG1L associated with plasma concentrations of methadone R- and S-enantiomers in heroin-dependent patients","volume":"12","author":"Yang","year":"2016","journal-title":"PLoS Genet."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617305675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617305675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:40:19Z","timestamp":1777545619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617305675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"alternative-id":["S0278584617305675"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.01.008","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}